DocDollars

Endotronix, Inc.

IL · United States · Reporting entity ID 100000801823

Total reported 2019–2025
$21.7M
#303 of 2,960 reporting companies — 0% of all reported industry payments
$220K in general payments across 1,016 records, plus $20.2M in research funding across 337 records.

How it breaks down

General payments $219,669
Research funding $20,224,131
Ownership & investment $1,269,245

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Endotronix, Inc. reported $21.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #303 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 1,016 general payment records and 337 research records were filed.

Common questions about Endotronix, Inc.

How much has Endotronix, Inc. paid US doctors?

Endotronix, Inc. reported $21,713,045 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $219,669 in general payments, $20,224,131 in research funding and $1,269,245 in ownership and investment interests.

How does Endotronix, Inc. rank among drug and device companies?

It ranks #303 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Endotronix, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.